원바이오젠 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 서영교, was filed 14 Aug 2024.
원바이오젠: what insiders have been doing
Every trade that managers of 원바이오젠 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. No insider at 원바이오젠 has published a filing in the past twelve months. The most recent one dates from 21 November 2024.
Our records for 원바이오젠 go back to 2021, with 3 purchases and 11 sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,966,101 sharesKRXDART:20241121000346
- ShareKRXDART:20240814002349Canonical exit: 27 Jun 2023 (T+90)
- 2,966,101 sharesKRXDART:20230907000240
- ShareKRXDART:20221222000570Canonical exit: 22 Mar 2023 (T+90)
- 2,966,101 sharesKRXDART:20221012000400
- 2,966,101 sharesKRXDART:20221012000402
- 2,966,101 sharesKRXDART:20221012000406
- 2,966,101 sharesKRXDART:20221012000404
- 2,966,101 sharesKRXDART:20221012000405
- 2,966,101 sharesKRXDART:20211105000427
- ShareKRXDART:20211001000266Canonical exit: 30 Dec 2021 (T+90)
- 2,966,101 sharesKRXDART:20210409001937
- ●Executives0DART
- 2,966,101 sharesKRXDART:20210308000377
- 2,966,101 sharesKRXDART:20210302000239
15 of 15 declarations
About 원바이오젠
원바이오젠 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of biopharmaceutical solutions.
